Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
Published on: May 26, 2023
Prospects of Exploring the Metal-Organic Framework for Combating Antimicrobial Resistance
Shakil Ahmed Polash1,2, Tushar Khare3,4, Vinay Kumar3,4
1Ian Potter NanoBiosensing Facility, NanoBiotechnology Research Laboratory (NBRL), School of Science, RMIT University, Melbourne, Victoria 3001, Australia.
Abstract:
Infectious diseases are a major public health concern globally. Infections caused by pathogens with resistance against commonly used antimicrobial drugs or antibiotics (known as antimicrobial resistance, AMR) are becoming extremely difficult to control. AMR has thus been declared as one of the top 10 global public health threats, as it has very limited solutions. The drying pipeline of effective antibiotics has further worsened the situation. There is no absolute treatment, and the limitations of existing methods warrant further development in antimicrobials. Recent developments in the nanomaterial field present them as promising therapeutics and effective alternative to conventional antibiotics and synthetic drugs. The metal-organic framework (MOF) is a recent addition to the antimicrobial category with superior properties. The MOF exerts antimicrobial action on a wide range of species and is highly biocompatible. Additionally, their porous structures allow the incorporation of biomolecules and drugs for synergistic antimicrobial action. This review provides an inclusive summary of the molecular events responsible for resistance development and current trends in antimicrobials to combat antibiotic resistance and explores the potential role of the MOF in tackling the drug-resistant microbial species.
Insights
Antimicrobial resistance (AMR) is a global threat with few solutions. Metal-organic frameworks (MOFs) show promise as novel therapeutics to combat drug-resistant microbes.
Area of Science:
- Microbiology
- Materials Science
- Public Health
Background:
- Antimicrobial resistance (AMR) poses a significant global health challenge, limiting treatment options for infectious diseases.
- The diminishing pipeline of effective antibiotics exacerbates the AMR crisis, necessitating novel therapeutic strategies.
- Existing treatments for drug-resistant pathogens are limited, highlighting the urgent need for innovative solutions.
Purpose of the Study:
- To review the molecular mechanisms underlying antimicrobial resistance development.
- To summarize current trends in antimicrobial drug development to combat resistance.
- To explore the potential of metal-organic frameworks (MOFs) as a novel therapeutic approach against drug-resistant microbes.
Main Methods:
- Literature review of molecular events in resistance development.
- Analysis of current antimicrobial research and development trends.
- Exploration of metal-organic framework (MOF) properties and applications in antimicrobial therapy.
Main Results:
- Metal-organic frameworks (MOFs) demonstrate broad-spectrum antimicrobial activity.
- MOFs exhibit high biocompatibility, making them suitable for therapeutic use.
- The porous nature of MOFs allows for drug incorporation, enabling synergistic antimicrobial effects.
Conclusions:
- Metal-organic frameworks (MOFs) represent a promising alternative to conventional antibiotics for combating antimicrobial resistance.
- MOFs offer a versatile platform for developing new antimicrobial agents with enhanced efficacy.
- Further research into MOFs is warranted to fully realize their potential in addressing the global AMR threat.
More Related Videos
07:14Author Spotlight: Experimental Approaches for the Synthesis of Low-Valent Metal-Organic Frameworks from Multitopic Phosphine Linkers
Published on: May 12, 2023
12:05Preparation of Hydrophobic Metal-Organic Frameworks via Plasma Enhanced Chemical Vapor Deposition of Perfluoroalkanes for the Removal of Ammonia
Published on: October 10, 2013
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Development of Antibiotic Resistance